DIA Biosimilars 2013

Clinical Ink

Thomas Littlejohn will be remembered for his innovation, spirit and desire to give back

Monday, April 11, 2011 03:07 AM

It’s the laughter that the staff of site group PMG Research say they will miss the most about Thomas W. Littlejohn III. His was a baritone laugh that could often be heard booming down the hallway at any of PMG’s 11 sites, usually accompanied by knee slapping and, if you were in the room with him, a jolly red face.

More... »

Cenduit: Now with Patient Reminders

Condolences

Thursday, March 31, 2011 01:37 PM

We deeply regret informing our readers of the recent deaths of Thomas Littlejohn, M.D. and Donna Beardsworth. Both Tommy and Donna devoted their professional lives to serving the clinical research enterprise:

More... »

CRF Health – eCOA Forum

Tablet PC with handwriting recognition for data capture could save industry time and money

Monday, March 14, 2011 07:05 AM

Over the last few years, the clinical research industry has increasingly adopted electronic data capture (EDC), embracing technology into the clinical trials process.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs